OBJECTIVES: This study aimed to determine the effect of a moderate, tailored exercise program on health-related quality of life, physical function, and arm volume in women receiving treatment for nonmetastatic breast cancer. METHODS:Women who were within 4-12 weeks of surgery for stageI-III breast cancer were randomized to center-based exercise and lymphedema education intervention or patient education. Functional assessment of cancer therapy-breast cancer (FACT-B), 6-min walk, and arm volume were performed at 3-month intervals through 18 months. Repeated measures analysis of covariance was used to model the total meters walked over time, FACT-B scores, and arm volume. Models were adjusted for baseline measurement, baseline affected arm volume, number of nodes removed, age, self-reported symptoms, baseline SF-12 mental and physical component scores, visit, and treatment group. RESULTS:Of the recruited 104 women, 82 completed all 18 months. Mean age (range) was 53.6 (32-82) years; 88% were Caucasian; 45% were employed full time; 44% were overweight; and 28% obese. Approximately, 46% had breast-conserving surgery; 79% had axillary node dissection; 59% received chemotherapy; and 64% received radiation. The intervention resulted in an average increase of 34.3 ml (SD = 12.8) versus patient education (p = 0.01). Changes in FACT-B scores and arm volumes were not significantly different. CONCLUSIONS: With this early exercise intervention after breast cancer diagnosis, a significant improvement was achieved in physical function, with no decline in health-related quality of life or detrimental effect on arm volume. IMPLICATIONS FOR CANCER SURVIVORS: Starting a supervised exercise regimen that is tailored to an individual's strength and stamina within 3 months following breast cancer surgery appears safe and may hasten improvements in physical functioning.
RCT Entities:
OBJECTIVES: This study aimed to determine the effect of a moderate, tailored exercise program on health-related quality of life, physical function, and arm volume in women receiving treatment for nonmetastatic breast cancer. METHODS:Women who were within 4-12 weeks of surgery for stage I-III breast cancer were randomized to center-based exercise and lymphedema education intervention or patient education. Functional assessment of cancer therapy-breast cancer (FACT-B), 6-min walk, and arm volume were performed at 3-month intervals through 18 months. Repeated measures analysis of covariance was used to model the total meters walked over time, FACT-B scores, and arm volume. Models were adjusted for baseline measurement, baseline affected arm volume, number of nodes removed, age, self-reported symptoms, baseline SF-12 mental and physical component scores, visit, and treatment group. RESULTS: Of the recruited 104 women, 82 completed all 18 months. Mean age (range) was 53.6 (32-82) years; 88% were Caucasian; 45% were employed full time; 44% were overweight; and 28% obese. Approximately, 46% had breast-conserving surgery; 79% had axillary node dissection; 59% received chemotherapy; and 64% received radiation. The intervention resulted in an average increase of 34.3 ml (SD = 12.8) versus patient education (p = 0.01). Changes in FACT-B scores and arm volumes were not significantly different. CONCLUSIONS: With this early exercise intervention after breast cancer diagnosis, a significant improvement was achieved in physical function, with no decline in health-related quality of life or detrimental effect on arm volume. IMPLICATIONS FOR CANCER SURVIVORS: Starting a supervised exercise regimen that is tailored to an individual's strength and stamina within 3 months following breast cancer surgery appears safe and may hasten improvements in physical functioning.
Authors: M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: Anne Fleissig; Lesley J Fallowfield; Carolyn I Langridge; Leigh Johnson; Robert G Newcombe; J Michael Dixon; Mark Kissin; Robert E Mansel Journal: Breast Cancer Res Treat Date: 2005-09-15 Impact factor: 4.872
Authors: Catherine M Alfano; Jeannette M Day; Mira L Katz; James E Herndon; Marisa A Bittoni; Jill M Oliveri; Kathleen Donohue; Electra D Paskett Journal: Psychooncology Date: 2009-02 Impact factor: 3.894
Authors: Wendy Demark-Wahnefried; Elizabeth C Clipp; Isaac M Lipkus; David Lobach; Denise Clutter Snyder; Richard Sloane; Bercedis Peterson; Jennifer M Macri; Cheryl L Rock; Colleen M McBride; William E Kraus Journal: J Clin Oncol Date: 2007-07-01 Impact factor: 44.544
Authors: Avelina C Padin; Stephanie J Wilson; Brittney E Bailey; William B Malarkey; Maryam B Lustberg; William B Farrar; Stephen P Povoski; Doreen M Agnese; Raquel E Reinbolt; Robert Wesolowski; Nicole Williams; Sagar Sardesai; Bhuvaneswari Ramaswamy; Anne M Noonan; Jeffrey B Vandeusen; Garrie J Haas; Janice K Kiecolt-Glaser Journal: Int J Behav Med Date: 2019-06
Authors: Irene de la Rosa Díaz; María Torres Lacomba; Ester Cerezo Téllez; Cristina Díaz Del Campo Gómez-Rico; Carlos Gutiérrez Ortega Journal: J Chiropr Med Date: 2016-11-23
Authors: Carolina Fernández-Lao; Irene Cantarero-Villanueva; Angelica Ariza-Garcia; Carol Courtney; César Fernández-de-las-Peñas; Manuel Arroyo-Morales Journal: Support Care Cancer Date: 2012-08-04 Impact factor: 3.603
Authors: Electra D Paskett; Jennifer Le-Rademacher; Jill M Oliveri; Heshan Liu; Drew K Seisler; Jeffrey A Sloan; Jane M Armer; Michelle J Naughton; Karen Hock; Michael Schwartz; Gary Unzeitig; Marianne Melnik; Lisa D Yee; Gini F Fleming; John R Taylor; Charles Loprinzi Journal: Cancer Date: 2020-10-20 Impact factor: 6.860